In this article, the authors reported that the breast cancer cell line was MDA-MB-231. However, a recent short tandem repeat authentication analysis has revealed that this cell line was another breast cancer cell line: MDA-MB-435. The conclusions of the paper are not affected.
We regret any inconvenience that this has caused.
Footnotes
DOI of original article: DOI 10.1593/neo.06304
